Delivery Order SPE2DB24D2205-SPE2DB24FDUVS
Award Date
5/30/24
Potential Completion Date
5/31/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Delivery Order valued at $3,021.61. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,361.42 and an ultimate completion date of October 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract is a delivery order under a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,375.17 Firm Fixed Price Delivery Order contract covers the supply of 4560593667 - BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, with a period of performance through April 17, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,026.52, is for the delivery of the drug BIDIL 20 MG-37.5 MG TABLET 90S. It is a firm-fixed-price contract with a completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,403.47 firm-fixed-price delivery order is for the supply of BIDIL 20 MG-37.5 MG TABLET 90S, with an ultimate completion date of October 20, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This contract award, valued at $16,219.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product, and has an ultimate completion date of December 13, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557681084 BIDIL 20 MG-37.5 MG TABLET 90S. The delivery order contract, valued at $5,221.49, has a firm fixed price and an ultimate completion date of June 30, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEBU9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,560.22 delivery order contract is for the supply of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through February 27, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply pharmaceutical products and medical supplies. The contract, valued at $6,250.13, is a firm fixed-price delivery order that covers the delivery of a specific pharmaceutical product, BIDIL 20 MG-37.5 MG TABLET 90S, to support federal healthcare programs. The contract has no set-aside designation, indicating it was awarded through full and open...
This federal contract award, valued at $4,475.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines,...